You are here

  • Home
  • Archive
  • Volume 2018, Issue
  • Successful use of subcutaneous ivermectin for the treatment of Strongyloides stercoralis hyperinfection in the setting of small bowel obstruction and paralytic ileus in the immunocompromised population

Article metrics

Article menu

Download PDFPDF

XML
Novel treatment (new drug/intervention; established drug/procedure in new situation)
CASE REPORT
Successful use of subcutaneous ivermectin for the treatment of Strongyloides stercoralis hyperinfection in the setting of small bowel obstruction and paralytic ileus in the immunocompromised population

 

Online download statistics by month:

Online download statistics by month: June 2018 to November 2023

AbstractFullPdf
Jun 2018240176160
Jul 2018783519
Aug 2018162213
Sep 2018342513
Oct 2018213120
Nov 2018404040
Dec 2018414117
Jan 2019615916
Feb 201910910741
Mar 201919218780
Apr 2019969025
May 2019767621
Jun 201980797
Jul 201910910515
Aug 201917317313
Sep 201912412211
Oct 201913713718
Nov 2019807412
Dec 2019837916
Jan 2020959136
Feb 2020747115
Mar 2020615516
Apr 202014113533
May 20201019823
Jun 2020514916
Jul 202012512313
Aug 202069618
Sep 20201121047
Oct 2020858531
Nov 2020656129
Dec 202014314144
Jan 2021250234106
Feb 202117216854
Mar 202110410352
Apr 202115415049
May 202116316354
Jun 202111611691
Jul 202113613594
Aug 202140540585
Sep 202130730652
Oct 202131731350
Nov 202118317848
Dec 202118818058
Jan 202221020438
Feb 202212312033
Mar 202211511112
Apr 2022979614
May 2022868640
Jun 2022888421
Jul 2022706827
Aug 2022776425
Sep 202210910433
Oct 2022958735
Nov 2022857726
Dec 2022696614
Jan 2023999829
Feb 2023898916
Mar 2023757315
Apr 20231171178
May 202311511122
Jun 202311111110
Jul 202311511315
Aug 202313713510
Sep 2023959537
Oct 202310210213
Nov 202310010012
Total778674942126